Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arif Hakan Önder

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2026
Small Cemetery WithinArif Hakan Önder
Journal of Cancer Policy|July 6, 2025
Memory, merit, and the machinery of silence: Reconstructing integrity in systems that do not discloseArif Hakan Önder
Accountability in Research|June 2, 2026
Two economies of medical knowledge: The publishing oligopoly and the clinical trial shadow professionArif Hakan Önder
The Oncologist|May 4, 2026
Cost, Context, and Confounding: Rethinking Real-World data Generation and Interpretation in Advanced NSCLCMehmet Mutlu Çatlı, Arif Hakan Önder
European Journal of Cancer (Oxford, England : 1990)|September 27, 2025
Colorectal cancer treatment commentary reviewArif Hakan Önder, Mehmet Mutlu Çatli
Cancer Biomarkers : Section a of Disease Markers|September 18, 2023
Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanomaIsmail Beypınar, Yıldız Sözel, Arif Hakan Önder
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2026
Dose matters: a dose-stratified real-world analysis of magnesium sulfate in preventing cisplatin-induced nephrotoxicityArif Hakan Önder, Yusuf İlhan, Mehmet Mutlu Çatlı
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 28, 2026
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkish Oncology CentersHalil Göksel Güzel, Arif Hakan Önder, Yusuf İlhan, et al.
Revista Da Associacao Medica Brasileira (1992)|January 15, 2026
Global awareness and integration of immunotherapy among thoracic surgeons: a multicenter survey studyMuharrem Özkaya, Nilay Cavusoglu Yalcin, Ayşegül Güler, et al.
BMC Cancer|May 7, 2022
Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational studyKadir Eser, Arif Hakan Önder, Emel Sezer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 23, 2026
Small Cemetery WithinArif Hakan Önder
Journal of Cancer Policy|July 6, 2025
Memory, merit, and the machinery of silence: Reconstructing integrity in systems that do not discloseArif Hakan Önder
Accountability in Research|June 2, 2026
Two economies of medical knowledge: The publishing oligopoly and the clinical trial shadow professionArif Hakan Önder
The Oncologist|May 4, 2026
Cost, Context, and Confounding: Rethinking Real-World data Generation and Interpretation in Advanced NSCLCMehmet Mutlu Çatlı, Arif Hakan Önder
European Journal of Cancer (Oxford, England : 1990)|September 27, 2025
Colorectal cancer treatment commentary reviewArif Hakan Önder, Mehmet Mutlu Çatli
Cancer Biomarkers : Section a of Disease Markers|September 18, 2023
Assessing the prognostic value of IMDC risk score for nivolumab-treated patients with renal cancer and malignant melanomaIsmail Beypınar, Yıldız Sözel, Arif Hakan Önder
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 7, 2026
Dose matters: a dose-stratified real-world analysis of magnesium sulfate in preventing cisplatin-induced nephrotoxicityArif Hakan Önder, Yusuf İlhan, Mehmet Mutlu Çatlı
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|January 28, 2026
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkish Oncology CentersHalil Göksel Güzel, Arif Hakan Önder, Yusuf İlhan, et al.
Revista Da Associacao Medica Brasileira (1992)|January 15, 2026
Global awareness and integration of immunotherapy among thoracic surgeons: a multicenter survey studyMuharrem Özkaya, Nilay Cavusoglu Yalcin, Ayşegül Güler, et al.
BMC Cancer|May 7, 2022
Proton pump inhibitors may reduce the efficacy of ribociclib and palbociclib in metastatic breast cancer patients based on an observational studyKadir Eser, Arif Hakan Önder, Emel Sezer, et al.
Pageof 2